Back to Featured Industry EventsDialing-Up the Precision in HR+, HER2- mBC With Biomarker-Guided Targeted Therapies and Next-Generation Endocrine Agents: Adapting to an Evolving Framework for Identifying Molecular Alterations, Personalizing Therapy Selection & Sequencing, and Addressing Endocrine Resistance
Dialing-Up the Precision in HR+, HER2- mBC With Biomarker-Guided Targeted Therapies and Next-Generation Endocrine Agents: Adapting to an Evolving Framework for Identifying Molecular Alterations, Personalizing Therapy Selection & Sequencing, and Addressing Endocrine Resistance
December 9 @ 7:00 pm – 10:00 pm CST